Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 618

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 618
---
    | $ | -15,291 | ​ | ​ | ​ | ​                       | $ | -21,040 | ​ | ​ | ​ | ​    | $ | -17,866 | ​ | ​ |
| Net cash provided by (used in) investing activities | ​ | ​ | ​                              | ​ |       — | ​ | ​ | ​ | ​    | ​ |  22,468 | ​ | ​ | ​ | ​                       | ​ |  22,468 | ​ | ​ | ​ | ​    | ​ | -22,000 | ​ | ​ |
| Net cash (used in) provided by financing activities | ​ | ​ | ​                              | ​ |      -9 | ​ | ​ | ​ | ​    | ​ |       2 | ​ | ​ | ​ | ​                       | ​ |       2 | ​ | ​ | ​ | ​    | ​ |       4 | ​ | ​ |
| Net (decrease) increase in cash                     | ​ | ​ | ​                              | $ | -13,481 | ​ | ​ | ​ | ​    | $ |   7,179 | ​ | ​ | ​ | ​                       | $ |   1,430 | ​ | ​ | ​ | ​    | $ | -39,862 | ​ | ​ |

353

TABLE OF CONTENTS

Operating Activities

Net cash used in operating activities was $13.5 million for the nine months ended September 30, 2024, reflecting a net loss of $16.7 million and net changes in operating assets and liabilities of $2.8 million, partially offset by non-cash charges for depreciation and amortization, stock-based compensation expense, and non-cash lease expense of $0.4 million. The net changes in operating assets and liabilities of $2.8 million was primarily driven by (i) a $2.0 million decrease in prepaid expenses and other current assets, attributable to the timing of patient enrollments, and (ii) a $0.9 million increase in accounts payable and accrued expenses, driven by the timing of invoices and payments.

Net cash used in operating activities was $15.3 million for the nine months ended September 30, 2023, reflecting a net loss of $13.0 million and net changes in operating assets and liabilities of $2.4 million, partially offset by non-cash charges for depreciation and amortization, stock-based compensation expense, non-cash lease expense